Let’s End HPV-related Cancers [briefing]

The American Association for Cancer Research (AACR), Moffitt Cancer Center and Biden Cancer Initiative, in partnership with American Cancer Society Cancer Action Network (ACS CAN), American Society of Clinical Oncology (ASCO), Association of American Cancer Institutes (AACI), Prevent Cancer Foundation, St. Jude Children’s Research Hospital, and the Union for International Cancer Control (UICC), invite you to a briefing:

Let’s End HPV-related Cancers

Thursday, June 27, 2019
12:00 pm – 1:30 pm Eastern

Rayburn House Office Building
Room 2044
Washington, DC

RSVP: 

• Congressional staff, general public
• Reporters

Briefing Speakers

Honorary Congressional Co-Chair:

• The Honorable Kathy Castor, U.S. Representative for the 14th District of Florida

Moderator:

• Gilbert S. Omenn, MD, PhD, Director, Center for Computational Medicine and Bioinformatics, University of Michigan; Chairman, Health Policy Subcommittee, American Association for Cancer Research

Keynote Speaker:

• Anna R. Giuliano, PhD, Founding Director, Center for Immunization and Infection Research in Cancer, Moffitt Cancer Center

Panelists:

• John T. Schiller, PhD, NIH Distinguished Investigator; Deputy Chief, Laboratory of Cellular Oncology, Center for Cancer Research, National Cancer Institute
• Melinda Wharton, MD, MPH, Director, Immunization Services Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention
• Vicki Benard, PhD, Chief, Cancer Surveillance Branch, Division of Cancer Prevention and Control, Centers for Disease Control and Prevention
• Jason T. Mendelsohn, Patient Advocate and Survivor, SupermanHPV.com

Background

Cancers caused by human papillomavirus (HPV) represent a significant disease burden in the United States and globally. Over 33,000 HPV-related cancers are diagnosed annually among men and women in the U.S. alone. In 2018, about one-third of these were cases of cervical cancer in women, and one-third were cancers of the oropharynx (back of the throat) in men, a number that has been rising in recent years. Globally, 630,000 cases of HPV-related cancers are diagnosed each year.

Due to advances in vaccination, screening and treatment, the elimination of cervical cancer – and ultimately all HPV-related cancers – is within reach. However, this goal will require a strong commitment from governments, public health organizations, health care workers, parents and other stakeholders around the world. The U.S. is in a position to lead by achieving elimination of HPV-related cancers domestically while also supporting global efforts.

We welcome you to attend this briefing, where you will hear from speakers representing a diverse range of expertise in domestic and global health about current interventions against HPV-related cancers and what needs to be done to achieve elimination.

RSVP: 

• Congressional staff, general public
• Reporters